JESSICA ROBERTS PIERCE: Open Payments
NPI 1063918118 · EVERGREEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 51 payments from 16 companies in 2025. Trend: 2023 $929 · 2024 $1,166 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $154 |
| GlaxoSmithKline, LLC. | 6 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $126 |
| AstraZeneca Pharmaceuticals LP | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| SHIELD THERAPEUTICS INC | 4 | $78 |
| ABBVIE INC. | 4 | $72 |
| Exact Sciences Corporation | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Ardelyx, Inc. | 1 | $27 |
Products named: MOUNJARO, TRELEGY ELLIPTA, Kerendia, REXULTI, FARXIGA, ACCRUFER, VRAYLAR, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
